Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy

Published:2015-10-20 Issue:8 Volume:76 Page:419-427
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Pereira Rui¹,Lago Paula¹²,Faria Raquel¹³,Torres Tiago¹⁴

Affiliation:

1. Instituto de Ciências Biomédicas Abel Salazar, Centro Hospitalar do Porto; Portugal

2. Department of Gastroenterology; Centro Hospitalar do Porto; Portugal

3. Clinical Immunology Unit; Centro Hospitalar do Porto; Portugal

4. Department of Dermatology; Centro Hospitalar do Porto; Portugal

Publisher

Wiley

Subject

Drug Discovery

Reference91 articles.

1. Anti-TNF therapy in Jordan: a focus on severe infections and tuberculosis;Alawneh;Biologics,2014

2. Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists;Askling;Ann Rheum Dis,2005a

3. Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists;Askling;Ann Rheum Dis,2005b

4. Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data;Askling;Pharmacoepidemiol. Drug Saf,2011

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malignancy, a real risk in patients using anti-TNF drugs for Crohn’s disease?;Journal of Case Reports and Images in Pathology;2024-08-29

2. Recent advances in the diagnosis and management of Behçet’s syndrome uveitis;Expert Review of Ophthalmology;2024-08-17

3. Zhisou powder displays therapeutic effect on chronic bronchitis through inhibiting PI3K/Akt/HIF-1α/VEGFA signaling pathway and reprograming metabolic pathway of arachidonic acid;Journal of Ethnopharmacology;2024-01

4. Behçet's disease uveitis;La Revue de Médecine Interne;2023-10

5. Preclinical Characterization of Pharmacologic NAD⁺ Boosting as a Promising Therapeutic Approach in Rheumatoid Arthritis;Arthritis & Rheumatology;2023-07-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3